Eli Lilly, Novo Nordisk Close To White House Deal On Obesity Drug Prices
Novo Nordisk makes the popular weight loss drug Wegovy.
The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss drugs at a lower price through Trump Rx, a source familiar confirmed to ABC News.
Under the pending agreements, a month's supply of the drugs will cost roughly $149, the source added.
An announcement is expected as soon as this week.
"Novo Nordisk is engaged in constructive discussions with the administration regarding the Most Favored Nation executive order. We remain focused on improving patient access and affordability, and we will continue to work to find solutions that help people access the medication they need," a spokesperson for the company told ABC News in a statement.
An Eli Lilly spokesperson said: "Lilly is in discussions with the administration to further expand patient access, preserve innovation, and promote affordability of our medicines. We do not have specific details to share at this time."
Novo Nordisk makes the popular weight loss drug Wegovy; Lilly is the maker of Zepbound.
This is a developing story. Please check back for updates.
Popular Products
-
Ashwagandha & Black Cumin Seed Oil$43.56$21.78 -
Shilajit Capsules for Strength & Vita...$43.99$29.78 -
Pre-Workout Supplement for Strength, ...$43.99$29.78 -
Centrum Multivitamin for Energy, Immu...$43.99$25.78 -
Bee Venom Capsules for Joint Support ...$43.56$21.78